Trials / Conditions / No-Reflow Phenomenon

No-Reflow Phenomenon

20 registered clinical trials studyying No-Reflow Phenomenon — 7 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Rivaroxaban for Slow Coronary Flow After PCI in STEMI NCT07195812	Second Affiliated Hospital, School of Medicine, Zhejiang University	Phase 4
Not Yet Recruiting	Validation of New Biomarkers for Predicting No-Reflow in STEMI Patients Undergoing Primary PCI NCT07132489	Assiut University	—
Recruiting	Adenosine Pre-Medication in Primary Percutaneous Coronary Intervention: A Randomized Control Trial NCT07536802	National Institute of Cardiovascular Diseases, Pakistan	Phase 4
Recruiting	Investigation of Brain Blood Flow Changes in Acute Ischemic Stroke Patients After Successful Endovascular Thro NCT07534319	University of Zurich	—
Active Not Recruiting	Empagliflozin for No-reflow Phenomenon in PCI for STEMI NCT06342141	Instituto Nacional de Cardiologia Ignacio Chavez	Phase 2
Recruiting	The Investigator Administers Intracoronary Adrenaline Via the Catheter in STEMI Patients During Primary PCI, A NCT06847568	Ain Shams University	Phase 3
Completed	Oral Nicorandil for Prevention of No Reflow Phenomenon in Anterior STEMI Patients Undergoing PPCI NCT07138508	Ain Shams University	Phase 1 / Phase 2
Not Yet Recruiting	Upfront Premedication For Reduction of Microvascular Obstruction and No-reflow in Treating ST-segment Elevatio NCT05393557	Cairo University	N/A
Recruiting	A Study to Evaluate the Impact of Pre-procedural Intracoronary Nicorandil Injection to PREVENT ReductioN of De NCT05427786	Korea University Anam Hospital	Phase 4
Completed	Genetic Determinants of the Coronary Microvascular Obstruction in PCI NCT05355532	Privolzhsky Research Medical University	—
Completed	Alpha Lipoic Acid Effect on No-Reflow Phenomenon NCT05360602	Ain Shams University	N/A
Unknown	the No-reflow in Diabetic Patients Treated With Primary Percutaneous Coronary Intervention (PCI) NCT04835974	Assiut University	N/A
Completed	Adrenaline for the Treatment of No-Reflow in Normotensive Patients NCT04699110	National Institute of Cardiovascular Diseases, Pakistan	Phase 4
Completed	The EPIVER Randomized Controlled Trial NCT04573751	Tomsk National Research Medical Center of the Russian Academy of Sciences	N/A
Completed	Mean Platelet Volume and STEMI Clinical Risk Scores in Prediction of Impaired Myocardial Perfusion In Acute ST NCT04785209	Assiut University	—
Unknown	NGAL and Its Association With the No-reflow Phenomenon in ST-elevation Myocardial Infarction NCT03264859	Sheba Medical Center	—
Completed	No Reflow Phenomenon Incidence and Predictors NCT04017169	Hull University Teaching Hospitals NHS Trust	—
Unknown	Ticagrelor and Clopidogrel on Reperfusion in Patients With AMI NCT02233790	First Hospital of China Medical University	Phase 4
Completed	Intracoronary Tirofiban on No-Reflow Phenomena NCT02054000	TC Erciyes University	Phase 4
Unknown	Analysis of Human Coronary Aspirate NCT01430884	Universität Duisburg-Essen	—